Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/30/18
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 08/19/20
End: 06/08/21
Due: 06/08/22
Phase: N/A
Priority: Normal
Start: 04/29/16
End: 07/29/20
Due: 07/29/21
Phase: N/A
Priority: Normal
Start: 06/18/10
End: 04/25/14
Due: 04/25/15
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| AMO-01 to Treat Adolescents and Adults With Phelan-McDermid Syndrome (PMS) and Co-morbid Epilepsy | NCT03493607 | Alexander Kolevzon | user2@example.com | None | 2018-05-30 | 2020-03-31 | 2021-03-31 | - | - | 2025-07-14 |
| Low-Dose Ketamine in Children With ADNP Syndrome | NCT04388774 | Alexander Kolevzon | user2@example.com | None | 2020-08-19 | 2021-06-08 | 2022-06-08 | - | - | 2025-07-14 |
| Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome | NCT02710084 | Alexander Kolevzon | user2@example.com | None | 2016-04-29 | 2020-07-29 | 2021-07-29 | - | - | 2025-07-14 |
| The Effects of Oxytocin on Complex Social Cognition in Autism Spectrum Disorders | NCT01183221 | Alexander Kolevzon | user2@example.com | None | 2010-06-18 | 2014-04-25 | 2015-04-25 | - | - | 2025-07-14 |